Quality Agreements and Managing Contract Supplier Quality

Similar documents
Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

While the recognition

Guidance for Industry Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

QUALITY ASSURANCE. Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT

Q10 PHARMACEUTICAL QUALITY SYSTEM

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

QUALITY AGREEMENT. The following Agreement has been concluded between

Session 4: Ensuring Product Quality Throughout the Supply Chain

ICH Quality Implementation Working Group POINTS TO CONSIDER

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Ensuring Quality & Regulatory Compliance when Collaborating with a Service Provider

Qualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008

A Customer-Focused Strategic Partner To The Pharmaceutical, Cosmetic & Natural Health Industries

GMP On Site Series. GMP Essentials

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

GxP Auditing, Remediation, and Staff Augmentation

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

GxP Auditing, Remediation, and Staff Augmentation

GAMP5 Validation for Dynamics 365

EU and FDA GMP Regulations: Overview and Comparison

Documenta tion and Records

THE COMPLETE GUIDE TO FDA-REGULATED SUPPLIER QUALIFICATION & QUALITY MANAGEMENT

GxP Auditing, Remediation, and Quality System Resourcing

Association of American Railroads Quality Assurance System Evaluation (QASE) Checklist Rev. 1/12/2017

Quality Assurance Policy and Procedures

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Quality System Manual - Section 00

Addressing Key FDA Citations with Training. Align UL EduNeering Courses to Top FDA Warning Letter Topics

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

Inspection of API Manufacturers & Update on Registration Process

Reducing Risks and Reaping Rewards

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

Document 2007 Rev 0 December 2005 Page 1 of 8

Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing

Annex 4. Guidance on good manufacturing practices: inspection report. Background

JFS-A/B/C Standards <Manufacturing> [Interpretations]

National Animal Supplement Council

The World Bank. Aide Memoire for use during GMP inspections

Guidance for Industry

Quality in Global Sourcing

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

PAI Inspections, Observations and Data Integrity

Table of Contents. Presented by

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

QUALITY ASSURANCE / QUALITY CONTROL POLICY

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS

QUALITY MANUAL DISTRIBUTION. Your Logo Here. Page 1 1 of 57. Rev.: A

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC

Ensuring Food Safety. Through Accredited Third-Party Conformity Assessment. An ANSI-ASQ National Accreditation Board White Paper

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

Osprey Technologies, LLC. Quality Manual ISO9001:2008 Rev -

Materials Management Traceability, CEPs and managing non-conforming sites

Pegasus Manufacturing SUPPLIER QUALITY REQUIREMENTS MANUAL

Defining and promoting excellence in the provision of mobile money services

PRODUCT CERTIFICATION REQUIREMENTS

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

The APIC Audit Programme Version 5, July 2017

Guidance for Industry

CMI Guidance Document

MANUAL QUALITY CONTROL & QUALITY ASSURANCE

Guidance on the Application. of ISO / IEC Accreditation International Association for Certifying Bodies

HACCP audit checklist

QUALITY MANUAL ECO# REVISION DATE MGR QA A 2/25/2008 R.Clement J.Haislip B 6/17/2008 T.Finneran J.Haislip

Life Sciences Courseware. Knowledge. Performance. Impact.

Annex 14 WHO guidelines for drafting a site master file 136

CBER Expectations Regarding Contract Manufacturing

FORGET CHICKEN LITTLE THE SKY IS FALLING: CURRENT ENTERPRISE RISK MANAGEMENT STRATEGIES FOR PRODUCT RECALLS AND CORPORATE COMPLIANCE MATTERS

The interface between Good Clinical Practice and Good Manufacturing Practice

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Role of Industrial Engineer in Compliance with FDA Regulations

World Bank Training Program on HIV/AIDS Drugs

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

Regulatory. Supplier Qualification A Review

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

Wilson-Hurd ATF Quality Manual

Supplier Quality Agreement

Good manufacturing practices

Questionnaire Layout:

HAVING THE TALK : PREPARING FOR NEW CONVERSATION-BASED INSPECTIONS

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

EPICOR, INCORPORATED QUALITY ASSURANCE MANUAL

QP Supplier Quality Requirements Manual. Purchasing. Dearborn Inc. Revision: E Page 1 of PURPOSE

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

Manual 058 Out of Specification Results Investigation

Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>

Supplier Quality Agreements

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department

Strategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017

D.P.E.LTD QUALITY CONTROL PROCEDURE NO 9 QUALITY CONTROL REQUIREMENTS FOR SUPPLIERS MASTER COPY

Transcription:

Quality Agreements and Managing Contract Supplier Quality American Society for Quality Lloyd Bailey November 3, 2005 Service Mark of The Dow Chemical Company TM Trademark of The Dow Chemical Company

Abstract Contract manufacturing and research service providers are increasingly being utilized to supplement 'in-house' capabilities. Formal Quality Agreements with these service providers are key to effectively managing regulatory compliance and satisfying product and service quality needs. In addition, they are useful in establishing successful service partner relationships, ensuring proper management of mutual quality system needs, and maximizing the value of the outsourcing opportunity. This presentation will describe what Quality Agreements encompass, their value, and the regulatory and practical basis for them. It will also describe typical content, the relationship with the business agreement, and the process for establishing, negotiating, and properly maintaining an effective Quality Agreement. Suggestions will also be provided to establish a framework for a collaborative partnership that creates value and facilitates project and product success. 2

The Dow Chemical Company A global leader in science and technology Annual sales $40 billion 43,000 employees Serving customers in 175 countries A Solutions-Oriented Science & Technology Company Our Mission To constantly improve what is essential to human progress by mastering science and technology 3

Dowpharma History Marion Merrell Dow Dowpharma / Dow Ventures includes BioAqueous Biological Services Dowpharma BCMS 2001 CMS 1995 2001 4

Dow and the Drug Life Cycle Drug Delivery Technology BioAqueous Pegylation ChelaMed Delivery Strategy Lead Optimize Process Development Formulation Development Phase II Clinical Supply Phase III Clinical Supply Phase I Phase II Phase III Launch & Commercial Manufacture Chemical Development Collaborative Research Synthesis Route Selection Product Characterization / Specification Development Chemical Scaffolds Process Optimization Engineering Scale-Up Chemical Manufacture Biologics Development Biologics Manufacture Clinical Supply Manufacture Fermentation/Isolation Process Development Product Characterization / Specification Development Clinical Supply Manufacture Commercial Mfg. Commercial Mfg. QA/ QC Regulatory Filing / Validation Strategy Validation & Facility Approval 5

Technology Platforms BioAqueous Solubilization Services Biopharmaceuticals ChelaMed Radiopharmaceutical Services Nucleic Acid Medicines PEGylation Plant Biopharmaceuticals Small Molecules Service Mark of The Dow Chemical Company 6

Quality Agreements What is a Quality Agreement Value and regulatory basis Content and structure Key areas Negotiating process On-going Maintenance Summary key points 7

What is a Quality Agreement? Formal document that defines the rules of engagement between the sponsor and client for proper management of mutual quality and quality regulatory needs in an outsourcing arrangement. Establishes mutual understanding of the quality management system to be applied and who is responsible (sponsor or client) for the execution of the various aspects of that quality management system. It s a get to know you exercise. Key early step in developing an effective, trusting, inter-dependant relationship. Ideally it is separate from the Commercial agreement, though linked. 8

Shared Quality and Regulatory Accountability The sponsor is ultimately responsible for the finished product --responsibility for quality and compliance can t be totally abdicated to contracting firm Sponsor and contract supplier both have regulatory obligations to satisfy Sponsor and contract supplier both have reputation and credibility at stake Success truly becomes a shared responsibility A good Quality Agreement defines these shared responsibilities 9

Drugs Pharmaceutical CGMP s (Part 211) 4. Control Outsourced Operations When outsourcing, a second party is hired under a contract to perform the operational processes that are part of a manufacturer s inherent responsibilities. For example, a manufacturer may hire another firm to package and label or perform CGMP regulation training. Quality systems call for contracts (quality agreements) that clearly describe the materials or service, quality specifications responsibilities, and communication mechanisms. Under a quality system, the manufacturer ensures that the contract firm is qualified. The firm s personnel should be adequately trained and monitored for performance according to their quality system, and the contract firm's and contracting manufacturer s quality standards should not conflict. It is critical in a quality system to ensure that the contracting manufacturer s officers are familiar with the specifics requirements of the contract. However, under the CGMP requirements, the QCU is responsible for approving or rejecting products or services provided under contract (see 211.22(a)). 10

Drug Actives From Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients : XVI. CONTRACT MANUFACTURERS (INCLUDING LABORATORIES) (16) All contract manufacturers (including laboratories) should comply with the GMP defined in this guidance. Special consideration should be given to the prevention of cross-contamination and to maintaining traceability. Companies should evaluate any contractors (including laboratories) to ensure GMP compliance of the specific operations occurring at the contractor sites. There should be a written and approved contract or formal agreement between a company and its contractors that defines in detail the GMP responsibilities, including the quality measures, of each party. A contract should permit a company to audit its contractor's facilities for compliance with GMP. Where subcontracting is allowed, a contractor should not pass to a third party any of the work entrusted to it under the contract without the company's prior evaluation and approval of the arrangements. Manufacturing and laboratory records should be kept at the site where the activity occurs and be readily available. Changes in the process, equipment, test methods, specifications, or other contractual requirements should not be made unless the contract giver is informed and approves the changes. 11

Biologics Cooperative Manufacturing Arrangements for Licensed Biologicals, August 1999 http://www.fda.gov/cber/gdlns/coopmfr.pdf Divided Manufacturing Arrangements More then one party owns the Product License and produce jointly Shared Manufacturing Arrangements License for parts of the entire process Contract Manufacturing Arrangements License holder is responsible to assure compliance with product and establishment standards 12

Medical Devices Good Manufacturing Practices (GMP) / Quality System (QS) Regulation (Devices) Contract Manufacturers A person(s) that manufactures a finished device under the terms of a contract with another manufacturer is a contract manufacturer. The agreement between the manufacturers should be documented in a written contract. Contract manufacturers of finished devices shall comply with applicable requirements of the quality system and shall register their establishment with FDA. Depending on the circumstances, both the contractor and manufacturer may be held jointly responsible by FDA for the activities performed. from http://www.fda.gov/cdrh/devadvice/32.html 13

Regulatory Basis Broadly required, can be considered a general requirement for any outsourcing arrangement Inspectors are asking for them -- defines scope of work, who s accountable for what, and therefore helps define scope of inspection Even where not strictly required, it s still good practice! 14

Linking Expectations with Delivery CMO Capability Sponsor Requirements Quality Agreement defines how CMO will satisfy Sponsor Requirements 15

Maximizing Value in the Relationship How work gets done the shared Quality Management System CMO s Standard Practices Sponsor s Expectations Efficiency is greatest in the overlapping area -- expand it through the Quality Agreement - worth spending time to find a CMO with a similar culture - work to understand differences are they real, meaningful? - be flexible, open opportunity to learn from one another - create a meaningful partnership through the dialogue 16

Relationship between Commercial and Quality Agreement Quality Agreement - product/service quality focused - agency reviewable - more easily updated, living doc - establishes communication mechanisms - relationship expectations -typically fewer signatories Commercial Agreement - pricing, delivery, indemnification - normally not a concern for the agency - relatively static - typically more signatories - legal requirements Can be one document, but quality agreement sections should be extractable for practical distribution and use 17

Typical Content Subject and Purpose of this Agreement Level of cgmp Expectation Definitions Raw Materials Specifications Procurement of Raw Materials Inspection, Testing and Labeling Storage and Handling of RM s BSE and TSE Compliance Qualified Supplier(s) MSDS Information Manufacturing and Packaging Specifications Site of Manufacture/Subcontracting Production and Facility Procedures Manufacturing Batch Documentation Lot Numbering, Date of Manufacture Labeling and Packaging Quality Assurance and Control Documentation Change Control Notice and Approval of Deviations Sampling/Retained Samples Testing General Inspection and Testing Laboratories/third party testing SPONSOR managed testing Dispute Resolution Release and Shipment of Product Certificates of Compliance Certificates of Analysis Stability testing, reporting Document Retention, location Requests for documentation First Three Lots Product Subsequent Lots of Product 18

Typical Content, con t Material Control Storage and Shipping Returned Goods Complaints and Recalls Rejection of Product by SPONSOR Reprocessing and Reworking Regulatory Documentation Audits Validation Approvals Annual Product Review Information Submissions to Regulatory Agencies Audits and Inspections by SPONSOR Regulatory Inspections Process and Analytical Validation Cleaning Validation Most firms have established their own quality agreement templates Breadth and level of detail will vary with nature of activity Keep quality agreements focused on expected scope of work, but challenge yourself to consider what ifs The form is much less important than the up-front dialog! 19

Key Areas Change Management Deviations, investigations Product Release GMP Audits Regulatory inspections 20

Management of Change (planned changes) Changes run the gamut in complexity and potential impact Varying levels of Sponsor involvement Need to define what is a change, and what should be done as a function of type of change Example changes are useful here to help characterize subjective terms (like major or minor etc) How and when to communicate can have an big impact on timing (are sponsor reps available?) How/who approves... and when? 21

Deviation management (unplanned changes) Every event is unique -- can have an big impact on $, schedules Expectations of what to do in response to deviations of varying severity vary widely Most important to build communication framework into quality agreement (and then communicate!) Investigation process can be involved who participates and how are decisions made and communicated? How/who approves? 22

Product Release Regulatory requirements for who is responsible is not clear Widely varying interest in direct Sponsor involvement Can have a significant impact on $, schedules Typically Sponsor has final responsibility, but who (and when) will: batch records be reviewed? analytical records be reviewed? investigations be closed out? differences of opinion be reconciled? Can drive man in plant needs 23

Routine GMP Audits You need to do them! Another good relationship building opportunity May need to consider intellectual property landscape Consider auditing logistics Contractors expect them at least annually, but too frequent, too many people, too long can be a burden (which just adds additional expense) 24

Agency Inspections Widely varying interest in direct participation in agency audits Will need some level of Sponsor involvement, min. via phone and fax, need to discuss logistics before the FDA is at the reception desk! With agency s systems focus to auditing, audits can quickly cross product and client lines Contractor is, in effect, your representative during an agency inspection make sure contractor is doing a good job representing your interests 25

Negotiating Try to consider scenarios you may be faced with best to decide how to handle the hypothetical case rather than when you re in the middle of a real issue Most meaningful discussions and agreements will be made Quality person to Quality person. Good to have the folks that will be executing the quality agreement involved in the negotiations to better understand intent. A lot of interaction work process will be established during the negotiating period. Try to capture. Alignment with business agreement needs to be regularly checked. Project leader typically involved in both discussions and should provide linkage. There will likely be direct cost implications. Work to understand each other -- great opportunity to starting building the relationship! 26

Execution and Maintenance Establish routine communication channels most information normally flows between QA and Project Leader peers in the two organizations (and they then need to communicate well between themselves and further within their organizations!) Consider establishing a formal process to document routine communication, decisions and transfer of records between companies Should review Quality Agreement annually, build in learning experiences. Review/update can be coupled with the annual audit, annual product review and/or quality management system review. Will evolved based on the business need and based on the maturity of the relationship typically moves from one of high level of control and oversight early in the relationship to more of a partnership as the relationship matures. 27

Summary key points Quality Agreements provide a framework for interaction and satisfying shared quality and regulatory obligations Most of the value with a Quality Agreement is the up-front discussion and mutual understanding it facilitates One size does not fit all -- quality agreements will look different for different situations Exceptions to the CMO s standard practices will add cost work to understand underlying needs and drivers Establish and reinforce routine communication channels it s key to an effective relationship 28